Although informed consent is critical for all research, there is increased ethical responsibility as individuals with intellectual or developmental disabilities (IDD) become the focus of more clinical trials. This study examined decisional capacity for informed consent to clinical trials in individuals with fragile X syndrome (FXS). Participants were 152 adolescents and adults (80 males, 72 females) with FXS who completed a measure of decisional capacity and a comprehensive battery of neurocognitive and psychiatric measures. Females outperformed males on all aspects of decisional capacity. The ability to understand aspects of the clinical trial had the strongest association with the ability to appreciate and reason about the decision. Scaffolding improved understanding, suggesting researchers can take steps to improve decisional capacity and the informed consent process.
Decisional capacity for informed consent in males and females with fragile X syndrome
Wheeler, A. C., Wylie, A., Raspa, M., Villagomez, A., Miller, K., Edwards, A., DeRamus, M., Appelbaum, P. S., & Bailey, D. B. (2020). Decisional capacity for informed consent in males and females with fragile X syndrome. Journal of Autism and Developmental Disorders, 50(5), 1725-1747. https://doi.org/10.1007/s10803-019-03930-4
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Treatment preferences among patients with mild-to-moderate atopic dermatitis
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Spatiotemporal analysis exploring the effect of law enforcement drug market disruptions on overdose, Indianapolis, Indiana, 2020-2021